Bayer gets written warning for illegally marketing unapproved drugs

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1663, 2008-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The UK Drug and Therapeutics Bulletin (DTB), has published a warning regarding the development and marketing of new forms of established drugs

Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The UK Drug and Therapeutics Bulletin (DTB), has published a warning regarding the development and marketing of new forms of established drugs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 516, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

The US FDA has asked Bayer to add a Boxed Warning to the labelling for nimodipine [Nimotop] capsules

Reactions Weekly, Vol. 1, Iss. 1087, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

AATF issues warning: "Bad Bugs Need Drugs"

Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Written Consent to Use the Drug in Children: The Problem of Off-Label Drugs

Current Pharmaceutical Design, Vol. 14, Iss. 8, 2008-03 ,pp. : 776-781

Bentham Science Publishers

Access to resources Recommend Favorite